Mindfulness training for cognitive impairment in people experiencing psychosis
Not Applicable
Completed
- Conditions
- Schizophrenia disorder and schizophrenia-related disorders following DSM-IV criteriaMental and Behavioural DisordersSchizophrenia disorder and schizophrenia-related disorders
- Registration Number
- ISRCTN52873519
- Lead Sponsor
- niversity of Balearic Islands
- Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35281772/ Daily life coping (added 21/11/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32994792/ Inhibitory control (added 21/11/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 56
Inclusion Criteria
1. Age between 18-65
2. Diagnosis of schizophrenia or schizoaffective disorder
3. No changes in psychiatric medication or hospitalization in last month
4. Have signed informed consent
5. Be able to understand and read Spanish language
6. Any gender
Exclusion Criteria
1. Significant cognitive impairment
2. Inability to attend mindfulness sessions
3. Posed a risk of violence to the researchers
4. Refused to participate or to sign informed consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Executive Functions are measured using the Trail Making Test, Stroop Test, Digits from WAIS-III, and the Controlled Oral Word Association Test at baseline and 26 weeks.<br> 2. Theory of Mind is measured using the Hinting Test and the Reading the Mind in the Eyes Test at baseline and 26 weeks<br> 3. General mindfulness awareness in daily life as a consequence of treatment are assessed by Mindfulness Attention Awareness Scale (MAAS) at baseline and 26 weeks<br>
- Secondary Outcome Measures
Name Time Method <br> 1. Symptoms are measured using videotapped Positive and Negative Syndrome Scale at baseline and 26 weeks<br> 2. Demographic information is measured using clinical record form at baseline<br>